Chiropractors in Ash Flat, AR Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Ronald Steven Yow, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 121 Hwy 62 W, Ash Flat, AR 72513 Phone: 870-994-7550 Fax: 870-994-7293 |
 Yow Chiropractic Clinic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 121 Hwy 62w, Ash Flat, AR 72513 Phone: 870-994-7550 Fax: 870-994-7293 |
Doncheff Chiropractic Clinic Chiropractor - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 75 Highway 62 412, Suite G, Ash Flat, AR 72513 Phone: 870-994-2888 |
Dr. Anthony Iwan Doncheff, D.C. Chiropractor - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 75 Highway 62 412, Suite G, Ash Flat, AR 72513 Phone: 870-994-2888 |
News Archive
Scientists map brain area that may help find human brain stem cells
A study led by a Johns Hopkins neurosurgeon has provided the first comprehensive map of a part of the adult human brain containing astrocytes, cells known to produce growth factors critical to the regeneration of damaged neural tissue and that potentially serve as brain stem cells.
University of Utah researchers knock out genes in nematode worms
Knocking genes out of action allows researchers to learn what genes do by seeing what goes wrong without them. University of Utah biologists pioneered the field. Mario Capecchi won a Nobel Prize for developing knockout mice. Kent Golic found a way to cripple fruit fly genes. Now, biologist Erik Jorgensen and colleagues have devised a procedure for knocking out genes in nematode worms.
Mutated Nesprin4 protein prevents hearing
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
Clarient receives patent for Mammostrat breast cancer prognostic test
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
› Verified 6 days ago
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Physical Therapists
Podiatrists
Audiologists